(Q44521662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bernadette Begue

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Nadine Cerf-Bensussan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

F M Ruemmele

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

1 reference

12 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

1260-1266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21994045%20AND%20SRC:MED&resulttype=core&format=json

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

14 February 2020

cites work

1 reference

Immunopathogenesis of inflammatory bowel disease: current concepts

21 January 2018

1 reference

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

21 January 2018

1 reference

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

21 January 2018

1 reference

Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice

21 January 2018

1 reference

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease

21 January 2018

1 reference

Late developmental plasticity in the T helper 17 lineage

21 January 2018

1 reference

Interleukin-23 drives intestinal inflammation through direct activity on T cells

21 January 2018

1 reference

Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production

21 January 2018

1 reference

Structure and signalling in the IL-17 receptor family

21 January 2018

1 reference

The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.

21 January 2018

1 reference

Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.

21 January 2018

1 reference

A protective function for interleukin 17A in T cell-mediated intestinal inflammation

21 January 2018

1 reference

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

21 January 2018

1 reference

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease

21 January 2018

1 reference

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

IL-23/IL-17 immunity as a hallmark of Crohn's disease

21 January 2018

1 reference

Pediatric inflammatory bowel diseases: coming of age.

21 January 2018

1 reference

Inflammatory bowel disease

21 January 2018

1 reference

The genetics and immunopathogenesis of inflammatory bowel disease

21 January 2018

1 reference

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

ATP drives lamina propria T(H)17 cell differentiation

21 January 2018

1 reference

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses

21 January 2018

1 reference

Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.

21 January 2018

1 reference

IL-17F: regulation, signaling and function in inflammation

21 January 2018

1 reference

Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase

21 January 2018

1 reference

Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells.

21 January 2018

1 reference

Interleukin-35: odd one out or part of the family?

21 January 2018

1 reference

IL-35-mediated induction of a potent regulatory T cell population.

21 January 2018

1 reference

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

21 January 2018

1 reference

Anti-interleukin-12 antibody for active Crohn's disease

21 January 2018

1 reference

After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?

21 January 2018

1 reference

Mixed results with modulation of TH-17 cells in human autoimmune diseases

21 January 2018

1 reference

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease

21 January 2018

1 reference